Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 147

Page
per page
  1. Doxazosin Mesylate
    A2884 Doxazosin Mesylate
    Summary: α1-adrenergic receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥13.69 mg/mL
  2. Prazosin HCl
    A5318 Prazosin HCl
    Summary: α1 and α2B-adrenoceptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥6.99 mg/mL
  3. Alfuzosin HCl
    A5173 Alfuzosin HCl
    Summary: α1 adrenoceptor antagonist,functionally uro-selective
      ≥19 mg/mL
  4. Silodosin
    A8521 Silodosin
    Summary: α1-adrenoceptor antagonist
      ≥24.78 mg/mL
  5. Mirabegron (YM178)
    A8474 Mirabegron (YM178)
    Target: adrenoceptor
    Summary: Selective β3-adrenoceptor agonist
  6. Guanfacine hydrochloride
    A3451 Guanfacine hydrochloride
    Summary: α2A-adrenoceptor agonist
      ≥14.13 mg/mL
  7. HOKU-81
    A3477 HOKU-81
    Summary: Bronchodilators,metabolite of tulobuterol
      Soluble in DMSO
  8. Indacaterol
    A3496 Indacaterol
    Summary: β2-agonist
      insoluble in H2O; ≥12.85 mg/mL
  9. Medetomidine
    A3592 Medetomidine
     1 Citation
    Summary: α2-adrenoceptor agonist
      ≥34.5 mg/mL
  10. Salmeterol xinafoate
    A3789 Salmeterol xinafoate
    Summary: β2-adrenergic receptor agonist
      ≥30.19 mg/mL

Items 1-10 of 147

Page
per page